1.
Emerg Infect Dis
; 24(8): 1516-1519, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29798745
RESUMO
We assessed the efficacy of standard 3-day courses of chloroquine and dihydroartemisinin/piperaquine against Plasmodium vivax malaria. Compared with chloroquine, dihydroartemisinin/piperaquine was faster in clearing asexual P. vivax parasites and blocking human-to-mosquito transmission. This drug combination was also more effective in preventing potential recurrences for >2 months.